학술논문

First-in-human phase 1 dose-escalation study of CAN04, a first-in-class interleukin-1 receptor accessory protein (IL1RAP) antibody in patients with solid tumours

Document Type

Article

Author

Robbrecht, D.; Eskens, F.; Jungels, C.; Aftimos, P.; Awada, A.; Sorensen, M.M.; Spanggaard, I.; Fretland, S.Ø.; Guren, T.K.; Liberg, D.; Svedman, C.; Thorsson, L.; Steeghs, N.

Source

In: British Journal of Cancer. (British Journal of Cancer, 1 April 2022, 126(7):1010-1017)

Subject

Language

English

ISSN

15321827
00070920

Online Access

Full Text (Nature Journals) Full Text (ProQuest Central) Open Access (EBSCO) Web of Science JCR 저널정보 Scopus Find it@PNU

이메일

부산대학교 도서관

Online Access

메일 발송